Guangdong Zhongsheng Pharmaceutical Co., Ltd.
SHZ: 002317.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yong Hong Chen
- Employees
- 1,775
- Headquarters
- Dongguan, China
- IPO year
- 2009
- Market cap
- CN¥19.2B
- Website
- https://www.zspcl.com
Loading 002317…
Loading profile data…Frequently asked questions about 002317
What does Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) do?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. The company offers Chinese and chemical medicines. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and...
Where does 002317.SZ trade?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002317.SZ in?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guangdong Zhongsheng Pharmaceutical Co., Ltd.?
Yong Hong Chen is the chief executive officer of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ).
Where is Guangdong Zhongsheng Pharmaceutical Co., Ltd. headquartered?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is headquartered in China.
Does 002317.SZ pay a dividend?
Yes — Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002317.SZ go public?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) completed its initial public offering in 2009.